Hypertension
Conditions
Interventions
191 patients agreed to participate, but 104 patients attended the consultations. It was a clinical trial compared to a single group before and after intervention. We emphasize that all subjects were f
Behavioural
Other
I02.233.332
Sponsors
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo
Thais Rodrigues Penaforte
Eligibility
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Hypertension, over 18 years in treatment.
Exclusion criteria
Exclusion criteria: Previously be gone, cognitive impairment, pregnant and lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome: The reduction in systolic blood pressure of 5-10 mmHg in one year of intervention. By analyzing the drugs used by the patient, the pharmacist verified the presence of possible drug related problems (DRP). On detecting a DRP, the pharmacist completed a form containing the breakdown of the drug in question (name, presentation, daily dose, dosage form and administration time), classified the DRP according to the PWDT, described the intervention to be performed and the proposed outcomes to be achieved with the intervention, established the form of monitoring of these results, designated the deadline for re-evaluation of clinical outcome and filled in the field concerning the adherence of intervention by the prescriber. In addition, the patient was informed and educated about the new behaviors in their pharmacotherapy when there was adherence by the physician. ;Outcome found: reduction of 17.8 mmHg and 7.1 mmHg in systolic and diastolic pressure, respectively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: Check the 50% improvement in adherence to treatment by Morisky-Green instrument used to measure adherence to pharmacological treatment. ;Expected outcome: 46% of adherence to treatment increased to 100% of the adherence.;Expected outcome: verify 5% improvement in the lipid profile of triglycerides, total cholesterol, cholesterol fractions (LDL) and (HDL). ;Expected outcome: Triglycerides (an improvement of 7.3% in the profile); Total cholesterol (an improvement of 3.5% in the profile); LDL (an improvement of 3.3% in the profile); HDL (an improvement of 4.3% in the profile).;Expected outcome: check, the SF-36 instrument, used to measure the quality of life of patients, improved quality of life by 10%.;Expected outcome: there was an increase of the score in the eight domains of the SF-36 (functional capacity, physical aspects, pain, general health, vitality, social functioning, emotional aspects and mental health), meaning on average, up to 66.8 85.3 points and 27.6% improvement in the quality of life of these patients.;Expected outcome: check the 10% reduction in cardiovascular risk calculated by the Framingham risk scale. ;Expected outcome: 14.65% reduced to 10.9% (35.6% reduction). | — |
Countries
Brazil
Contacts
Public ContactMaurilio Cazarim
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo
Outcome results
None listed